Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000008

CHIEF FINANCIAL OFFICER acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-23 Option exercise +10,000 $2.45 $24,500 211,100 D
Derivatives
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-23 Option exercise · Stock Options −10,000 $2.45 $24,500 816,567 D
Loading xslF345X05/form4-01232026_090158.xml…